Harmony Biosciences Holdings HRMY
NASDAQ HRMY
$39.51 +0.25 (+0.62%)
As of: Oct 1, 2026 · 1:13 PM EDT

Harmony Biosciences Holdings (HRMY) Revenue (2020 - 2026)

Updated

Harmony Biosciences Holdings (HRMY) posted Revenue of $261.28 million for Q2 2026, up 30.3% from $200.49 million a year earlier and up 21.3% from the prior quarter.

Analysis

Harmony Biosciences Holdings (HRMY) Revenue (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Revenue at Harmony Biosciences Holdings was $959.9 million, up 24.3% year-over-year; for FY2025, it came in at $868.45 million, up 21.5% from FY2024.

  • Annual Revenue has increased for five consecutive years, with a five-year compound annual growth rate of 40.3% (FY2020 to FY2025).
  • In prior years, Harmony Biosciences Holdings' Revenue was $714.73 million in FY2024 (+22.8%), $582.02 million in FY2023 (+32.9%), $437.86 million in FY2022 (+43.4%) and $305.44 million in FY2021 (+91.2%).
  • The Q2 2026 figure stands as the highest quarterly Revenue in data going back to Q1 2020.
  • On a year-over-year basis, Revenue has increased in each of the last 22 quarters, with growth averaging 21.0% over the last eight quarters.
  • Across the past five years, year-over-year growth in Revenue ran from 16.0% in Q2 2025 to 77.0% in Q3 2021.
  • According to Business Quant data, Revenue for the three prior quarters was $215.39 million (Q1 2026), $243.78 million (Q4 2025) and $239.46 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.31 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 16.99 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 15.38 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 7.80 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 3.33 Bn
10 Harmony Biosciences Holdings 2.28 Bn -474.81 Mn 198.08 Mn 261.28 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 261.28 Mn
Mar 31, 2026 215.39 Mn
Dec 31, 2025 243.78 Mn
Sep 30, 2025 239.46 Mn
Jun 30, 2025 200.49 Mn
Mar 31, 2025 184.73 Mn
Dec 31, 2024 201.27 Mn
Sep 30, 2024 186.04 Mn
Jun 30, 2024 172.81 Mn
Mar 31, 2024 154.62 Mn
Dec 31, 2023 168.41 Mn
Sep 30, 2023 160.27 Mn
Jun 30, 2023 134.22 Mn
Mar 31, 2023 119.13 Mn
Dec 31, 2022 128.31 Mn
Sep 30, 2022 117.21 Mn
Jun 30, 2022 107.03 Mn
Mar 31, 2022 85.31 Mn
Dec 31, 2021 91.21 Mn
Sep 30, 2021 80.73 Mn
API Access

Harmony Biosciences Holdings Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=HRMY&period=max&api_key=YOUR_API_KEY